Intrinsiqq
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc.

ODTX

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$513M
EPS-$5.46
P/E-3.11
P/FCF-3.88
EV/EBITDA-2.17
FCF Yield–
Div. Yield–
Net Debt/FCF1.2x
Odyssey Therapeutics, Inc. intrinsic value
52-Week Range
$15.56$28.76

Profitability & Returns

Revenue (TTM)

-$697K

▼ -33.5% YoY

Net Income (TTM)

-$165M

▼ -14.9% YoY

Op. Margin

23763.99%

▼ -2391.4pp YoY

ROIC

-438.13%

▼ -111.4pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$132M

▼ -10.5% YoY

Op. Cash Flow (TTM)

-$132M

▼ -10.2% YoY

Net Debt

-$154M

Net Cash Position

Cash & Equiv.

$181M

Continue Research

Peers

Biotechnology · Pick stocks to compare with ODTX

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Held by ETFs

ODTX is in 3 US ETFs. The largest of them, with ODTX's weight in each:

Odyssey Therapeutics (ODTX) in three numbers

Quality score
25/100
Best check: margin trend, +36631.8pp. Weakest: return on capital, -438.1%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-3.11
Negative: a loss over the last twelve months. Price to free cash flow -3.88.
Financials

Questions about Odyssey Therapeutics

Is Odyssey Therapeutics a high-quality business?

Odyssey Therapeutics scores 25 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is margin trend at +36631.8pp, and its weakest is return on capital at -438.1%. The Quality tab shows every check against its target.

Does Odyssey Therapeutics (ODTX) pay a dividend?

No. Odyssey Therapeutics (ODTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ODTX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.